IFNγ induces monopoiesis and inhibits neutrophil development during inflammation

Blood

Volumn 119, Issue 6, 2012, Pages 1543-1554

  De Bruin, Alexander M ^a   Libregts, Sten F ^a,b   Valkhof, Marijke ^c   Boon, Louis ^d   Touw, Ivo P ^c   Nolte, Martijn A ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d BIOCEROS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR PU 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; EXPERIMENTAL MODEL; HEMATOPOIESIS; IMMUNOSTIMULATION; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MONOCYTE; MOUSE; MYELOID PROGENITOR CELL; MYELOPOIESIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; VIRUS INFECTION; WILD TYPE;

EID: 84856830351     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-07-367706     Document Type: Article

References (56)

1. Ueda Y, Kondo M, Kelsoe G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med. 2005; 201(11):1771-1780. (Pubitemid 41002896)
2. Basu S, Hodgson G, Zhang HH, et al. "Emergency" granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Blood. 2000;95(12):3725-3733. (Pubitemid 30412843)
3. Dunay IR, Damatta RA, Fux B, et al. Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity. 2008;29(2):306-317.
4. Rosen H, Gordon S, North RJ. Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells. J Exp Med. 1989;170(1): 27-37. (Pubitemid 19179693)
5. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000; 404(6774):193-197. (Pubitemid 30154488)
6. Rieger MA, Hoppe PS, Smejkal BM, Eitelhuber AC, Schroeder T. Hematopoietic cytokines can instruct lineage choice. Science. 2009;325(5937): 217-218.
7. Lieschke GJ, Grail D, Hodgson G, et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994;84(6):1737-1746. (Pubitemid 24286121)
8. Liu F, Wu HY, Wesselschmidt R, Kornaga T, Link DC. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity. 1996; 5(5):491-501. (Pubitemid 26423476)
9. Tian SS, Lamb P, Seidel HM, Stein RB, Rosen J. Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood. 1994;84(6):1760-1764.
10. Cheers C, Haigh AM, Kelso A, et al. Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect Immun. 1988;56(1):247-251. (Pubitemid 18032159)
11. Zhang H, Nguyen-Jackson H, Panopoulos AD, et al. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood. 2010; 116(14):2462-2471.
12. Friedman AD. Transcriptional control of granulocyte and monocyte development. Oncogene. 2007;26(47):6816-6828. (Pubitemid 47585105)
13. Serbina NV, Hohl TM, Cherny M, Pamer EG. Selective expansion of the monocytic lineage directed by bacterial infection. J Immunol. 2009; 183(3):1900-1910.
14. Santangelo S, Gamelli RL, Shankar R. Myeloid commitment shifts toward monocytopoiesis after thermal injury and sepsis. Ann Surg. 2001;233(1): 97-106. (Pubitemid 32042779)
15. Silva KD, Gamelli RL, Shankar R. Bone marrow stem cell and progenitor response to injury. Wound Repair Regen. 2001;9(6):495-500. (Pubitemid 34266729)
16. Rodriguez S, Chora A, Goumnerov B, et al. Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood. 2009;114(19):4064-4076.
17. Slifka MK, Whitmire JK, Ahmed R. Bone marrow contains virus-specific cytotoxic T lymphocytes. Blood. 1997;90(5):2103-2108. (Pubitemid 27377327)
18. Lee SW, Park Y, So T, et al. Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells. Nat Immunol. 2008;9(8):917-926.
19. Nolte MA, Arens R, van Os R, et al. Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nat Immunol. 2005;6(4):412-418.
20. de Bruin AM, Buitenhuis M, van der Sluijs KF, et al. Eosinophil differentiation in the bone marrow is inhibited by T cell-derived IFN-gamma. Blood. 2010;116(14):2559-2569.
21. Binder D, van den Broek MF, Kagi D, et al. Aplastic anemia rescued by exhaustion of cytokinesecreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus. J Exp Med. 1998;187(11):1903-1920. (Pubitemid 28262453)
22. Schoenborn JR, Wilson CB. Regulation of interferon- gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41-101. (Pubitemid 350018717)
23. Arens R, Tesselaar K, Baars PA, et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity. 2001;15(5): 801-812. (Pubitemid 34008507)
24. Libregts SF, Gutiérrez L, de Bruin AM, et al. Chronic IFNγ production in mice induces anemia by reducing erythrocyte lifespan and inhibiting erythropoiesis through an IRF-1/PU. 1-axis. Blood. 2011;118(9):2578-2588.
25. MacNamara KC, Oduro K, Martin O, et al. Infection- induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-gamma signaling. J Immunol. 2011;186(2): 1032-1043.
26. Murray PJ, Young RA, Daley GQ. Hematopoietic remodeling in interferon-gamma-deficient mice infected with mycobacteria. Blood. 1998;91(8): 2914-2924. (Pubitemid 28227542)
27. Norose K, Naoi K, Fang H, Yano A. In vivo study of toxoplasmic parasitemia using interferongamma- deficient mice: absolute cell number of leukocytes, parasite load and cell susceptibility. Parasitol Int. 2008;57(4):447-453.
28. Hermans MH, van de Geijn GJ, Antonissen C, et al. Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood. 2003;101(7):2584-2590. (Pubitemid 36857617)
29. van Gisbergen KP, van Olffen RW, van Beek J, et al. Protective CD8 T cell memory is impaired during chronic CD70-driven costimulation. J Immunol. 2009;182(9):5352-5362.
30. Ohnmacht C, Pullner A, van Rooijen N, Voehringer D. Analysis of eosinophil turnover in vivo reveals their active recruitment to and prolonged survival in the peritoneal cavity. J Immunol. 2007;179(7): 4766-4774.
31. Ward AC, Hermans MH, Smith L, et al. Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration. Blood. 1999;93(1):113-124. (Pubitemid 29019395)
32. Gorbachev AV, Fairchild RL. CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12. J Immunol. 2004;173(4):2443-2452. (Pubitemid 39063101)
33. Binder D, Fehr J, Hengartner H, Zinkernagel RM. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J Exp Med. 1997;185(3):517-530. (Pubitemid 27078370)
34. Kanno Y, Kozak CA, Schindler C, et al. The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds. Mol Cell Biol. 1993;13(7):3951-3963. (Pubitemid 23187623)
35. Lee CK, Raz R, Gimeno R, et al. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity. 2002;17(1):63-72. (Pubitemid 34874619)
36. Croker BA, Metcalf D, Robb L, et al. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity. 2004;20(2):153-165. (Pubitemid 38258392)
37. Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 2001;19(5):378-387. (Pubitemid 32900080)
38. Hörtner M, Nielsch U, Mayr LM, et al. Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction. J Immunol. 2002;169(3):1219- 1227. (Pubitemid 34809162)
39. Snoeck HW, Van Bockstaele DR, Nys G, et al. Interferon gamma selectively inhibits very primitive CD342+. J Exp Med. 1994;180(3):1177-1182.
40. Snoeck HW, Lardon F, Lenjou M, et al. Interferongamma and interleukin-4 reciprocally regulate the production of monocytes/macrophages and neutrophils through a direct effect on committed monopotential bone marrow progenitor cells. Eur J Immunol. 1993;23(5):1072-1077. (Pubitemid 23120168)
41. Tishon A, Lewicki H, Rall G, Von HM, Oldstone MB. An essential role for type 1 interferon-gamma in terminating persistent viral infection. Virology. 1995;212(1):244-250.
42. Sloand E, Kim S, Maciejewski JP, et al. Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood. 2002;100(4):1185-1191. (Pubitemid 34864270)
43. Young NS, Scheinberg P, Calado RT. Aplastic anemia. Curr Opin Hematol. 2008;15(3):162-168. (Pubitemid 351507566)
44. Tsujimura H, Nagamura-Inoue T, Tamura T, Ozato K. IFN consensus sequence binding protein/IFN regulatory factor-8 guides bone marrow progenitor cells toward the macrophage lineage. J Immunol. 2002;169(3):1261-1269. (Pubitemid 34809167)
45. Holtschke T, Lohler J, Kanno Y, et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell. 1996;87(2):307-317. (Pubitemid 26359008)
46. Tamura T, Nagamura-Inoue T, Shmeltzer Z, Kuwata T, Ozato K. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity. 2000;13(2):155-165.
47. Dahl R, Walsh JC, Lancki D, et al. Regulation of macrophage and neutrophil cell fates by the PU. 1:C/EBPalpha ratio and granulocyte colonystimulating factor. Nat Immunol. 2003;4(10):1029-1036. (Pubitemid 37265925)
48. Meraro D, Hashmueli S, Koren B, et al. Proteinprotein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors. J Immunol. 1999;163(12):6468-6478.
49. Li L, Jin H, Xu J, Shi Y, Wen Z. Irf8 regulates macrophage versus neutrophil fate during zebrafish primitive myelopoiesis. Blood. 2011;117(4):1359-1369.
50. Hirai H, Zhang P, Dayaram T, et al. C/EBPbeta is required for 'emergency' granulopoiesis. Nat Immunol. 2006;7(7):732-739.
51. Domínguez PM, Ardavin C. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev. 2010;234(1):90-104.
52. Tumpey TM, Chen SH, Oakes JE, Lausch RN. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol. 1996;70(2):898-904. (Pubitemid 26029006)
53. Tate MD, Brooks AG, Reading PC. The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir Res. 2008;9(1):57.
54. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol. 2008;83(1):64-70.
55. Wojtasiak M, Pickett DL, Tate MD, et al. Depletion of Gr-1+, but not Ly6G+, immune cells exacerbates virus replication and disease in an intranasal model of herpes simplex virus type 1 infection. J Gen Virol. 2010;91(Pt 9):2158-2166.
56. Tate MD, Deng YM, Jones JE, et al. Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol. 2009;183(11):7441-7450.